Faculty Opinions recommendation of The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease.

2010 ◽  
Author(s):  
Roger Barker ◽  
Wei-Li Kuan
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Motor Function ◽  
Rat Model ◽  
Important Determinant ◽  
Dopamine Neuron ◽  
Ventral Mesencephalon ◽  
Recovery Of Motor Function

Xenotransplantation of Porcine Fetal Ventral Mesencephalon in a Rat Model of Parkinson's Disease: Functional Recovery and Graft Morphology

1996 ◽  
Vol 140 (1) ◽  
pp. 1-13 ◽  
Author(s):  
Wendy R. Galpern ◽  
Lindsay H. Burns ◽  
Terrence W. Deacon ◽  
Jonathan Dinsmore ◽  
Ole Isacson
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Functional Recovery ◽  
Rat Model ◽  
Ventral Mesencephalon ◽  
Graft Morphology

scholarly journals Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson's disease

2012 ◽  
Vol 234 (2) ◽  
pp. 482-487 ◽  
Author(s):  
Patricia K. Sonsalla ◽  
Lai-Yoong Wong ◽  
Suzan L. Harris ◽  
Jason R. Richardson ◽  
Ida Khobahy ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Rat Model ◽  
Dopamine Neuron ◽  
Neuron Loss ◽  
Caffeine Treatment

Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat model

2017 ◽  
Vol 795 ◽  
pp. 28-35 ◽  
Author(s):  
Tuane Bazanella Sampaio ◽  
Simone Pinton ◽  
Juliana Trevisan da Rocha ◽  
Bibiana Mozzaquatro Gai ◽  
Cristina Wayne Nogueira
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Motor Function ◽  
Rat Model ◽  
Diphenyl Diselenide

Activation of V2 vasopressin receptors induces recovery of motor function in patients with stroke, Parkinson’s disease and parkinsonism of different nature

2016 ◽  
Vol 14 (4) ◽  
pp. 52-60
Author(s):  
Svetlana G Belokoskova ◽  
Sergei G Tsikunov
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Clinical Trials ◽  
Motor Function ◽  
Movement Disorders ◽  
Effect Of Therapy ◽  
Vasopressin Receptors ◽  
V2 Vasopressin Receptors ◽  
Positive Effect ◽  
Recovery Of Motor Function

In clinical trials have studied effectiveness of agonist of V2 vasopressin receptors, 1-dezamino-8-D-arginine-vasopressin (DDAVP) in correction of movement disorders in patients with stroke, Parkinson’s disease and parkinsonism. Therapy received 15 patients with the stroke and 21 patients with the Parkinson’s disease and parkinsonism. Positive effect of therapy was observed in 67% of cases of stroke and in 73% cases of parkinsonian syndrome. After therapy of DDAVP movement disorders were regressed in patients with light hemiparesis after stroke. In patients with a tremor-rigid shape and akinetic-rigid form of the disease major movement disorders: tremor, rigidity, bradykinesia and hypokinesia were regressed. Except the disorders of movements affective and cognitive abnormalities were decreased. There was established that DDAVP effective in correction of disorders of voluntary and involuntary component of movements function in patients with the focal vascular and neurodegenerative diseases.

Xenografting of fetal pig ventral mesencephalon corrects motor asymmetry in the rat model of Parkinson's disease

1989 ◽  
Vol 77 (2) ◽  
pp. 329-336 ◽  
Author(s):  
T. K. Huffaker ◽  
B. D. Boss ◽  
A. S. Morgan ◽  
N. T. Neff ◽  
R. E. Strecker ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Rat Model ◽  
Motor Asymmetry ◽  
Ventral Mesencephalon ◽  
Fetal Pig
Sign in / Sign up

Export Citation Format

Share Document